1-3 of 3
Gabriela Chiosis
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Correction: Prostate-specific membrane antigen cleavage of vitamin B9 stimulates oncogenic signaling through metabotropic glutamate receptors

Charalambos Kaittanis, Chrysafis Andreou, Haley Hieronymus, Ninghui Mao, Catherine A. Foss, Matthias Eiber, Gregor Weirich, Palak Panchal, Anuradha Gopalan, Juan Zurita, Samuel Achilefu, Gabriela Chiosis, Vladimir Ponomarev, Markus Schwaiger, Brett S. Carver, Martin G. Pomper, Jan Grimm
Journal: Journal of Experimental Medicine
J Exp Med (2017) 215 (1): 377.
https://doi.org/10.1084/jem.2017105211212017c
Published: 28 November 2017
View article titled, Correction: Prostate-specific membrane antigen cleavage of vitamin B9 stimulates oncogenic signaling through metabotropic glutamate receptors
Open the PDF for Correction: Prostate-specific membrane antigen cleavage of vitamin B9 stimulates oncogenic signaling through metabotropic glutamate receptors in another window
Journal Articles

Prostate-specific membrane antigen cleavage of vitamin B9 stimulates oncogenic signaling through metabotropic glutamate receptors

Charalambos Kaittanis, Chrysafis Andreou, Haley Hieronymus, Ninghui Mao, Catherine A. Foss, Matthias Eiber, Gregor Weirich, Palak Panchal, Anuradha Gopalan, Juan Zurita, Samuel Achilefu, Gabriela Chiosis, Vladimir Ponomarev, Markus Schwaiger, Brett S. Carver, Martin G. Pomper, Jan Grimm
Journal: Journal of Experimental Medicine
J Exp Med (2017) 215 (1): 159–175.
https://doi.org/10.1084/jem.20171052
Published: 15 November 2017
View article titled, Prostate-specific membrane antigen cleavage of vitamin B9 stimulates oncogenic signaling through metabotropic glutamate receptors
Open the PDF for Prostate-specific membrane antigen cleavage of vitamin B9 stimulates oncogenic signaling through metabotropic glutamate receptors in another window
Includes: Supplementary data
Journal Articles

Targeting of KRAS mutant tumors by HSP90 inhibitors involves degradation of STK33

Ninel Azoitei, Christopher M. Hoffmann, Jana M. Ellegast, Claudia R. Ball, Kerstin Obermayer, Ulrike Gößele, Britta Koch, Katrin Faber, Felicitas Genze, Mark Schrader, Hans A. Kestler, Hartmut Döhner, Gabriela Chiosis, Hanno Glimm, Stefan Fröhling, Claudia Scholl
Journal: Journal of Experimental Medicine
J Exp Med (2012) 209 (4): 697–711.
https://doi.org/10.1084/jem.20111910
Published: 26 March 2012
View article titled, Targeting of KRAS mutant tumors by HSP90 inhibitors involves degradation of STK33
Open the PDF for Targeting of KRAS mutant tumors by HSP90 inhibitors involves degradation of STK33 in another window